載入...
Risperidone versus other atypical antipsychotics for schizophrenia
BACKGROUND: In many countries of the industrialised world second-generation (“atypical”) antipsychotics (SGAs) have become the first line drug treatment for people with schizophrenia. The question as to whether and if so how much the effects of the various SGAs differ is a matter of debate. In this...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4167865/ https://ncbi.nlm.nih.gov/pubmed/21249678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006626.pub2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|